Cytopenias in Hospitalized Patients of Corona Virus Infection(COVID-19) During First and Other Waves

Demographic, Clinical and laboratory data as well as outcome of total 202 COVID-19 patients who were Polymerase Chain Reaction (PCR) positive and admitted in Fatima memorial Hospital, Lahore, Pakistan, was collected during first and other waves. Data of First wave is from May 2020 to July 2020, second wave from early November to Mid December 2020 and third wave from Mid march to June 2021. Investigator analyzed the data on basis of Systemic immune inflammatory index (SII) as well hematological parameters of First Wave were compared to other waves of COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Corona Virus Infection Anemia Blood Platelet Disorders COVID-19 Coronaviridae Infections Coronavirus Infections Cytopenia Hematologic Diseases Hemic and Lymphatic Diseases Infections Leukocyte Disorders Leukopenia Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Thrombocytopenia Virus Diseases

Age range

10 year–95 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fatima memorial Hospital

Lahore, Punjab Province, 54000, Pakistan

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

COVID-19 Positive Hospitalized patients
All genders

Exclusion criteria

Patients with Known hematological disorders
Patients with known chronic Liver Disease

Treatment and study plan

Primary outcomes

Cytopenias in Hospitalized Patients of COVID-19 During First and Other waves

Time frame: 4 weeks

extent of cytopenias is being measured in COVID-19 hospitalized patients.

Sponsors and collaborators

Lead sponsor

Fatima Memorial Hospital

Other

Registry information

Official study title

Cytopenias in Hospitalized Patients of COVID-19 During First and Other Waves

Important dates

Study start: 2020
Primary completion: 2021
Study completion: 2021
First posted: Feb 28, 2022
Registry last updated: Feb 28, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed